Multi-modal Neuroimaging in Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 20, 2020

Study Completion Date

September 20, 2022

Conditions
Alzheimer's Disease
Interventions
BEHAVIORAL

Memory assessment

Neuropsycological tests including clinical and original tests to compare differences between each populations.

BIOLOGICAL

Circulating biomarkers measure

ELISA tests from blood samples to compare differences between each populations.

GENETIC

ApoE4

Evaluation of apolipoprotein E polymorphism as a risk factor.

OTHER

Brain imaging examination MRI and PET examinations

Structural and functional MRI FDG-PET to compare differences between each populations.

Trial Locations (7)

14000

GIP Cyceron, Caen

Inserm - EPHE - University of Caen U1077, Caen

14033

University Hospital Côte de Nacre, Caen

35033

University Hospital Pontchaillou, Rennes

37044

University Hospital Tours, Tours

59037

University Hospital Roger Salengro, Lille

76031

University Hospital Rouen, Rouen

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Caen

OTHER

NCT01638949 - Multi-modal Neuroimaging in Alzheimer's Disease | Biotech Hunter | Biotech Hunter